Shu‐Min Huang

1.3k total citations · 1 hit paper
46 papers, 923 citations indexed

About

Shu‐Min Huang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Sociology and Political Science. According to data from OpenAlex, Shu‐Min Huang has authored 46 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Sociology and Political Science. Recurrent topics in Shu‐Min Huang's work include Advanced Breast Cancer Therapies (7 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Shu‐Min Huang is often cited by papers focused on Advanced Breast Cancer Therapies (7 papers), HER2/EGFR in Cancer Research (4 papers) and Cancer Treatment and Pharmacology (4 papers). Shu‐Min Huang collaborates with scholars based in Taiwan, China and United States. Shu‐Min Huang's co-authors include Xiaolin Yu, Ziyu Huang, Ran Bi, Qinghui Zeng, Pi Guo, Jialong Xu, Yuliang Chen, Haisheng Wu, Xiaoxin Huang and Tianming Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Shu‐Min Huang

41 papers receiving 847 citations

Hit Papers

Detection and Analysis of Microplastics in Human Sputum 2022 2026 2023 2024 2022 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Detection and Analysis of Microplastics in Human Sputum
    2022 379 citations Shu‐Min Huang, Xiaoxin Huang et al. Environmental Science & Technology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu‐Min Huang Taiwan 12 364 239 159 148 127 46 923
Peidong Yang United States 20 358 1.0× 148 0.6× 64 0.4× 323 2.2× 28 0.2× 111 1.6k
Anna Karlsson Sweden 22 108 0.3× 85 0.4× 196 1.2× 25 0.2× 127 1.0× 50 1.4k
Yunyun Zhang China 17 256 0.7× 34 0.1× 71 0.4× 21 0.1× 44 0.3× 92 1.1k
Cheng Yan-ping China 14 240 0.7× 119 0.5× 52 0.3× 8 0.1× 79 0.6× 30 720
Astrid de Leeuw Netherlands 14 26 0.1× 48 0.2× 51 0.3× 226 1.5× 104 0.8× 37 1.6k
Xing Yao China 16 154 0.4× 10 0.0× 28 0.2× 42 0.3× 24 0.2× 35 1.1k
Mark Powell United Kingdom 15 24 0.1× 22 0.1× 199 1.3× 177 1.2× 52 0.4× 31 1.2k
Sung‐Mi Kim South Korea 17 28 0.1× 8 0.0× 48 0.3× 108 0.7× 29 0.2× 47 858

Countries citing papers authored by Shu‐Min Huang

Since Specialization
Citations

This map shows the geographic impact of Shu‐Min Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu‐Min Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu‐Min Huang more than expected).

Fields of papers citing papers by Shu‐Min Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu‐Min Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu‐Min Huang. The network helps show where Shu‐Min Huang may publish in the future.

Co-authorship network of co-authors of Shu‐Min Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Shu‐Min Huang. A scholar is included among the top collaborators of Shu‐Min Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu‐Min Huang. Shu‐Min Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Kang, Ling Tian, Wenxin Cao, et al.. (2025). Histone acetylation homeodynamics navigates cell survival and apoptosis. Nature Communications. 16(1). 11358–11358.
2.
Tong, Lin, Shu‐Min Huang, Wenhao Zhang, et al.. (2025). 20E-induced Kr-h1 expression facilitates developmental transitions depending on chromosome accessibility of BR-C enhancers. Proceedings of the National Academy of Sciences. 122(32). e2509608122–e2509608122. 2 indexed citations
3.
Chen, I‐Chun, Ching‐Hung Lin, Dwan‐Ying Chang, et al.. (2024). Hormone therapy enhances anti-PD1 efficacy in premenopausal estrogen receptor-positive and HER2-negative advanced breast cancer. Cell Reports Medicine. 6(1). 101879–101879. 3 indexed citations
4.
5.
6.
7.
Chen, Tom Wei‐Wu, Ming‐Shen Dai, Ching‐Hung Lin, et al.. (2023). Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer. Breast Cancer Research and Treatment. 201(3). 377–385. 5 indexed citations
8.
Lin, Ching‐Hung, I‐Chun Chen, Ying‐Chun Shen, et al.. (2023). Disparity in survival benefits of pembrolizumab between Asian and non‐Asian patients with advanced cancers: A systematic review and meta‐regression analysis. Cancer Medicine. 12(19). 20035–20051. 1 indexed citations
9.
10.
Huang, Shu‐Min, Xiaoxin Huang, Ran Bi, et al.. (2022). Detection and Analysis of Microplastics in Human Sputum. Environmental Science & Technology. 56(4). 2476–2486. 379 indexed citations breakdown →
11.
12.
Chen, I‐Chun, Ching‐Hung Lin, Dwan‐Ying Chang, et al.. (2021). Abstract CT028: A pilot study of pembrolizumab and exemestane/leuprolide in premenopausal hormone receptor positive/HER2 negative locally advanced or metastatic breast cancer (PEER). Cancer Research. 81(13_Supplement). CT028–CT028.
13.
Lin, Ching‐Hung, Yoon Sim Yap, Kyung-Hun Lee, et al.. (2019). Contrasting Epidemiology and Clinicopathology of Female Breast Cancer in Asians vs the US Population. JNCI Journal of the National Cancer Institute. 111(12). 1298–1306. 82 indexed citations
14.
Zhong, Changqing, et al.. (2019). Factors influencing the attention to home storage of medicines in China. BMC Public Health. 19(1). 833–833. 23 indexed citations
15.
Chen, Cong, Shu‐Min Huang, Aihua Huang, et al.. (2018). Risk factors for lymph node metastasis and the impact of adjuvant chemotherapy on ductal carcinoma in situ with microinvasion: a population-based study. OncoTargets and Therapy. Volume 11. 9071–9080. 6 indexed citations
16.
Chen, Tom Wei‐Wu, Dah‐Cherng Yeh, Tsu‐Yi Chao, et al.. (2017). A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer. Japanese Journal of Clinical Oncology. 48(3). 242–247. 2 indexed citations
17.
Lu, Yen‐Shen, Tom Wei‐Wu Chen, Ching‐Hung Lin, et al.. (2015). Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain Radiotherapy. Clinical Cancer Research. 21(8). 1851–1858. 71 indexed citations
18.
Chen, Tom Wei‐Wu, Dwan‐Ying Chang, Shu‐Min Huang, et al.. (2013). The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines. The Breast. 22(6). 1148–1154. 5 indexed citations
19.
Kuo, Yu‐Hsuan, Ching‐Hung Lin, Wen‐Yi Shau, et al.. (2012). Dynamics of circulating endothelial cells and endothelial progenitor cells in breast cancer patients receiving cytotoxic chemotherapy. BMC Cancer. 12(1). 620–620. 17 indexed citations
20.
Deng, Xiangzheng, Shu‐Min Huang, Jinyan Zhan, & Tao Zhao. (2004). A Methodology Framework for Regional Land-use Change Studies based on Landsat TM images: A Case Study in Northeast China. Chinese Journal of Population Resources and Environment. 2(4). 3–11. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peidong Yang Breakdown of academic impact, for papers by Anna Karlsson Breakdown of academic impact, for papers by Yunyun Zhang Breakdown of academic impact, for papers by Cheng Yan-ping Breakdown of academic impact, for papers by Astrid de Leeuw Breakdown of academic impact, for papers by Xing Yao Breakdown of academic impact, for papers by Mark Powell Breakdown of academic impact, for papers by Sung‐Mi Kim
Rankless by CCL
2026